Cholera vaccine use is associated with a reduced risk of death in patients with colorectal cancer: A population-based study
Gastroenterology Oct 02, 2017
Ji J, et al. - This population-based study aimed to investigate whether cholera Vaccine (killed Vibrio cholerae O1 whole cells and recombinant cholera toxin B subunit) use was associated with a reduced risk of death in patients with colorectal cancer (CRC). Findings correlated administration of the cholera vaccine with decreased risk of death from CRC and overall mortality, after CRC diagnosis.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
